News tagged with clinical trials

Related topics: patients , cancer , cancer cells , vaccine , food and drug administration

Circadian clock-Angelman syndrome link established

Monitoring participants' biological clocks may be the quickest way to determine the effectiveness of experimental drugs currently under development to treat Angelman syndrome: a debilitating genetic disorder ...

Feb 05, 2015
popularity 5 / 5 (3) | comments 0

New ovarian cancer drug Lynparza one step closer

Ovarian cancer patients throughout Europe and the United States could soon be treated with a new drug discovered through pioneering research at the University of Sheffield funded by Yorkshire Cancer Research.

Feb 16, 2015
popularity 5 / 5 (3) | comments 0

Clarithromycin as an anti-cancer agent

An antibiotic may join the ranks of drugs suitable for repurposing as anti-cancer treatments, according to new research from the Repurposing Drugs in Oncology (ReDO) project published in ecancermedicalscience.

Feb 25, 2015
popularity 5 / 5 (2) | comments 0

Researchers reprogram tumor's cells to attack itself

Inserting a specific strain of bacteria into the microenvironment of aggressive ovarian cancer transforms the behavior of tumor cells from suppression to immunostimulation, researchers at Norris Cotton Cancer ...

Feb 04, 2015
popularity 5 / 5 (1) | comments 0

Clinical trial

In clinical trials are conducted to allow safety and efficacy data to be collected for new drugs or devices. These trials can only take place once satisfactory information has been gathered on the quality of the product and its non-clinical safety, and Health Authority/Ethics Committee approval is granted in the country where the trial is taking place.

Depending on the type of product and the stage of its development, investigators enroll healthy volunteers and/or patients into small pilot studies initially, followed by larger scale studies in patients that often compare the new product with the currently prescribed treatment. As positive safety and efficacy data are gathered, the number of patients is typically increased. Clinical trials can vary in size from a single center in one country to multicenter trials in multiple countries.

Due to the sizable cost a full series of clinical trials may incur, the burden of paying for all the necessary people and services is usually borne by the sponsor who may be the pharmaceutical or biotechnology company that developed the agent under study. Since the diversity of roles may exceed resources of the sponsor, often a clinical trial is managed by an outsourced partner such as a contract research organization

This text uses material from Wikipedia licensed under CC BY-SA